PF-08046045/SGN-35T

· Seagen

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PF-08046045/SGN-35T, covering 2026-01-26 to 2026-01-26. Get the full timeline:

Most recent: Clinical Trial Update: A Safety Study of PF-08046045/SGN-35T in Adults With Advanced Cancers [Phase 1]